arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Bodhi Tree Biotechnology Inc

BDTB
Price unavailable
Industrials ·Services-Management Consulting Services ·USServices-Management Consulting Services
2 Visible periods
15 Metrics
Peer-ranked Benchmarks
Price Chart
23
Health
Poor
Bearish
auto_awesome

Analytical Summary

Bodhi Tree Biotechnology Inc faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth
Op. Margin
ROIC -125.6%
FCF / Share $-0.01
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close.
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
6
Cash Quality
66

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 2 years · 9 quarters